212 related articles for article (PubMed ID: 10456621)
1. Withdrawal of warfarin after deep vein thrombosis: effects of a low fixed dose on rebound thrombin generation.
Ascani A; Iorio A; Agnelli G
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):291-5. PubMed ID: 10456621
[TBL] [Abstract][Full Text] [Related]
2. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study.
Palareti G; Legnani C; Guazzaloca G; Frascaro M; Grauso F; De Rosa F; Fortunato G; Coccheri S
Thromb Haemost; 1994 Aug; 72(2):222-6. PubMed ID: 7831656
[TBL] [Abstract][Full Text] [Related]
3. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
4. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
5. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
6. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
[TBL] [Abstract][Full Text] [Related]
7. Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation.
Koefoed BG; Feddersen C; Gulløv AL; Petersen P
Thromb Haemost; 1997 May; 77(5):845-8. PubMed ID: 9184390
[TBL] [Abstract][Full Text] [Related]
8. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
9. Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction.
MacCallum PK; Rudnicka AR; Rumley A; Meade TW; Lowe GD
Br J Haematol; 2004 Nov; 127(4):448-50. PubMed ID: 15521923
[TBL] [Abstract][Full Text] [Related]
10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
11. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
12. [Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].
Vorob'eva NM; Ermolina OV; Balakhonova TV; Dobrovol'skiĭ AB; Titaeva EV; Kirienko AI; Panchenko EP
Ter Arkh; 2008; 80(7):50-4. PubMed ID: 18763596
[TBL] [Abstract][Full Text] [Related]
13. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
[TBL] [Abstract][Full Text] [Related]
14. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment.
Brodin E; Seljeflot I; Arnesen H; Hurlen M; Appelbom H; Hansen JB
Thromb Res; 2009 Feb; 123(4):573-9. PubMed ID: 18474393
[TBL] [Abstract][Full Text] [Related]
15. Warfarin sensitivity after mechanical heart valve replacement.
Rose JP; Rihn TL; Long SF
Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
[TBL] [Abstract][Full Text] [Related]
16. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial.
Falanga A; Levine MN; Consonni R; Gritti G; Delaini F; Oldani E; Julian JA; Barbui T
Thromb Haemost; 1998 Jan; 79(1):23-7. PubMed ID: 9459316
[TBL] [Abstract][Full Text] [Related]
17. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
Harper P; Monahan K; Baker B
Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
[TBL] [Abstract][Full Text] [Related]
18. Comparison of enoxaparin and unfractionated heparin on thrombin generation in acute coronary syndromes without ST-segment elevation.
Salvioni A; Casilli F; Assanelli E; Grazi M; Marenzi G; Guazzi MD
Thromb Haemost; 2001 Oct; 86(4):991-4. PubMed ID: 11686357
[TBL] [Abstract][Full Text] [Related]
19. Effects of fixed minidose warfarin on coagulation and fibrinolysis following major gynaecological surgery.
MacCallum PK; Thomson JM; Poller L
Thromb Haemost; 1990 Dec; 64(4):511-5. PubMed ID: 2084936
[TBL] [Abstract][Full Text] [Related]
20. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy.
Parra D; Beckey NP; Stevens GR
Pharmacotherapy; 2007 May; 27(5):675-83. PubMed ID: 17461702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
